IPO Profile: Zosano Pharma Corp
Zosano, a drug developer backed by NEA, HBM Healthcare Investments and others, raised $49.5 million in its IPO
1 February 2015•1 min read
Zosano, a drug developer backed by NEA, HBM Healthcare Investments and others, raised $49.5 million in its IPO
